硫化背后的遗传学:对气道改造的影响
Charikleia Ntenti1,2,3, Eleni Papakonstantinou2,3, Liana Fidani4
11st Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Journal of personalized medicine
|March 28, 2024
概括
SUMF1基因的遗传变异可能通过影响细胞外基质硫化,导致慢性阻塞性肺病 (COPD). 这项研究探讨了SUMF1.
科学领域:
- 肺部医学 肺部医学
- 遗传学 遗传学 是一个
- 生物化学 生物化学
背景情况:
- 慢性阻塞性肺病 (COPD) 涉及由于慢性炎症和刺激物暴露而导致的气道加厚.
- 在COPD中,空气流量限制受遗传因素和环境暴露之间的相互作用的影响.
- 基因多态性与COPD的发展和进展越来越相关.
研究的目的:
- 调查SUMF1基因在COPD病变发生过程中的作用.
- 探索SUMF1基因变异,细胞外基因硫化和气道改造之间的联系.
- 审查有关COPD中SUMF1失调的当前文献以及COPD和喘的潜在治疗策略.
主要方法:
- 关于SUMF1,COPD和气道改造的现有研究的全面文献综述.
- 对将基因多态与COPD联系起来的实验发现的分析.
- 检查硫酶活性在COPD患者中的作用.
主要成果:
- SUMF1基因变异可能导致肺细胞外基质中的硫化不平衡,可能导致COPD发病.
- SUMF1的失调与COPD的进展和异常的硫酶活性有关.
- SUMF1在溶酶体功能和细胞外基质维护中发挥作用,对呼吸系统健康至关重要.
结论:
- SUMF1基因变异代表了COPD病变发生的潜在遗传因素.
- 了解SUMF1在硫化和气道改造中的作用,可能为COPD和喘提供新的治疗点.
- 进一步研究SUMF1的遗传复杂性是有必要的,以改善呼吸系统疾病的管理.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Cystic Fibrosis: Pathogenesis
229
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
229
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma: Pathogenesis and Management
394
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
394
Cystic Fibrosis: Management
161
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
161


